SYNCOM FORMULATIONS (INDIA)
Back to Income Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹0.27 | ₹0.21 | ₹0.23 | ₹0.13 | ₹0.13 |
What is the latest Earnings Per Share (EPS) of SYNCOM FORMULATIONS (INDIA) ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹0.27 |
| Mar2024 | ₹0.21 |
| Mar2023 | ₹0.23 |
| Mar2022 | ₹0.13 |
| Mar2017 | ₹0.13 |
How is Earnings Per Share (EPS) of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.27 | 28.57 | |
| Mar2024 | ₹0.21 | -8.70 | |
| Mar2023 | ₹0.23 | 76.92 | |
| Mar2022 | ₹0.13 | 0.00 | |
| Mar2017 | ₹0.13 | - | |
Compare Earnings Per Share (EPS) of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,409.1 Cr | -2.2% | -6.4% | -32.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,581.0 Cr | -1.8% | 4.1% | -1.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,051.0 Cr | -2.8% | -3.7% | 2.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,367.0 Cr | -0.2% | -0.9% | 12.9% | Stock Analytics | |
| CIPLA | ₹120,289.0 Cr | -2.1% | -1.7% | 0.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,421.0 Cr | -2% | 3.3% | -0.6% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -2.2% |
-6.4% |
-32.1% |
| SENSEX | -0.8% |
1% |
3.2% |
You may also like the below Video Courses